170 related articles for article (PubMed ID: 34799078)
1. Steroid-responsive aseptic meningitis after BNT162b2 SARS-CoV-2 vaccine.
Reis Carneiro D; Matos A; Morgadinho A
Rev Neurol (Paris); 2022; 178(1-2):160-161. PubMed ID: 34799078
[No Abstract] [Full Text] [Related]
2. Diagnosing SARS-CoV-2 vaccination associated aseptic meningitis is intricate.
Finsterer J
Rev Neurol (Paris); 2022; 178(1-2):156-157. PubMed ID: 34998524
[No Abstract] [Full Text] [Related]
3. Aseptic meningitis after SARS-CoV-2 Pfizer/BioNTech vaccination.
Dupon V; Arnaert S; Van Haute E; Vulsteke F; Diet G; De Schoenmakere G
Acta Clin Belg; 2022 Dec; 77(6):976-979. PubMed ID: 34882515
[TBL] [Abstract][Full Text] [Related]
4. Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine.
Saito K; Shimizu T; Suzuki-Inoue K; Ishida T; Wada Y
Neurol Sci; 2021 Nov; 42(11):4433-4435. PubMed ID: 34378098
[No Abstract] [Full Text] [Related]
5. Aseptic Meningitis Following the Second Dose of Comirnaty Vaccination in an Adolescent Patient: A Case Report.
Lee JK
Pediatr Infect Dis J; 2022 Feb; 41(2):172-174. PubMed ID: 34711784
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of SARS-CoV-2 Antibody Response to CoronaVac followed by Booster Dose of BNT162b2 Vaccine.
Fonseca MHG; Pinto ACMD; Silva MFS; de Melo ACL; Vasconcelos GS; Dos Santos ER; de Carvalho Araújo FM; de Andrade LOM
Emerg Infect Dis; 2022 Jun; 28(6):1237-1240. PubMed ID: 35421324
[TBL] [Abstract][Full Text] [Related]
7. Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.
Haller MC; Kaiser RA; Langthaler S; Brandstetter C; Apfalter P; Kerschner H; Cejka D
Transpl Int; 2021; 35():10026. PubMed ID: 35185359
[No Abstract] [Full Text] [Related]
8. Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia, Italy.
Sansone E; Tiraboschi M; Sala E; Albini E; Lombardo M; Castelli F; De Palma G
J Infect; 2021 Jul; 83(1):e17-e18. PubMed ID: 33965428
[No Abstract] [Full Text] [Related]
9. Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle?
Mazzatenta C; Piccolo V; Pace G; Romano I; Argenziano G; Bassi A
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e543-e545. PubMed ID: 34048614
[No Abstract] [Full Text] [Related]
10. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
[TBL] [Abstract][Full Text] [Related]
11. Pityriasis lichenoides chronica after BNT162b2 Pfizer-BioNTech vaccine: A novel cutaneous reaction after SARS-CoV-2 vaccine.
Drago F; Ciccarese G; Guadagno A; Parodi A
J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):e979-e981. PubMed ID: 35841285
[No Abstract] [Full Text] [Related]
12. Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.
Yau K; Abe KT; Naimark D; Oliver MJ; Perl J; Leis JA; Bolotin S; Tran V; Mullin SI; Shadowitz E; Gonzalez A; Sukovic T; Garnham-Takaoka J; de Launay KQ; Takaoka A; Straus SE; McGeer AJ; Chan CT; Colwill K; Gingras AC; Hladunewich MA
JAMA Netw Open; 2021 Sep; 4(9):e2123622. PubMed ID: 34473256
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing antibody titers elicited by CoronaVac and BNT162b2 vaccines in health care workers with and without prior SARS-CoV-2 infection.
Wolff MJ; Acevedo ML; Núñez MA; Lafourcade M; Gaete-Argel A; Soto-Rifo R; Valiente-Echeverría F
J Travel Med; 2022 May; 29(3):. PubMed ID: 35134229
[TBL] [Abstract][Full Text] [Related]
14. BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.
Piccolo V; Bassi A; Argenziano G; Mazzatenta C; Cutrone M; Neri I; Grimalt R; Russo T
J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e493-e494. PubMed ID: 33914966
[No Abstract] [Full Text] [Related]
15. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months.
Ponticelli D; Antonazzo IC; Caci G; Vitale A; Della Ragione G; Romano ML; Borrelli M; Schiavone B; Polosa R; Ferrara P
J Travel Med; 2021 Dec; 28(8):. PubMed ID: 34697627
[No Abstract] [Full Text] [Related]
17. Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19.
Bautista García J; Peña Ortega P; Bonilla Fernández JA; Cárdenes León A; Ramírez Burgos L; Caballero Dorta E
Rev Esp Cardiol (Engl Ed); 2021 Sep; 74(9):812-814. PubMed ID: 33994339
[No Abstract] [Full Text] [Related]
18. BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?
Cotugno N; Pighi C; Morrocchi E; Ruggiero A; Amodio D; Medri C; Colagrossi L; Russo C; Di Cesare S; Santilli V; Manno EC; Zangari P; Giancotta C; Bernardi S; Nicolosi L; Ciofi Degli Atti M; Raponi M; Zaffina S; Alfieri S; Kirk R; Perno CF; Rossi P; Amodeo A; Palma P
Transplantation; 2022 Feb; 106(2):e158-e160. PubMed ID: 34954734
[No Abstract] [Full Text] [Related]
19. Second dose of COVID-19 vaccination in immediate reactions to the first BNT162b2.
Rosa Duque JS; Leung D; Au EYL; Lau YL
Pediatr Allergy Immunol; 2022 Jan; 33(1):e13683. PubMed ID: 34669219
[No Abstract] [Full Text] [Related]
20. Humoral immune response after different SARS-CoV-2 vaccination regimens.
Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A
BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
